News

InflaRx Engages with Investors at Key Upcoming Conferences

InflaRx Engages with Investors at Key Upcoming Conferences

InflaRx N.V. Welcomes Investor Engagement in Upcoming Summits

InflaRx N.V. (Nasdaq: IFRX), a leading biopharmaceutical company based in Germany, is gearing up to take part in several noteworthy investor conferences this summer. As a trailblazer in developing innovative therapeutics aimed at combating inflammation by targeting the complement system, InflaRx is poised to showcase its advancements and connect with potential investors.

Jeffries Global Healthcare Conference

The company is set to participate in the prestigious Jefferies Global Healthcare Conference happening shortly. This event will occur from June 3rd to June 5th. As part of this gathering, InflaRx will host an investor presentation on June 4th at 7:35 AM ET. The presentation aims to share insights into the company’s strategic direction and innovations in the biopharmaceutical landscape. After the presentation, there will be opportunities for one-on-one investor meetings, highlighting InflaRx's commitment to fostering direct relationships with its investors.

Oppenheimer Innovators in I&I Summit

Continuing its proactive engagement with the investment community, InflaRx will also appear at the Oppenheimer Innovators in Inflammation and Immunology Summit. Scheduled for June 25th, this summit will feature InflaRx on a panel discussing recent advancements in dermatology, specifically focusing on atopic dermatitis (AD) and chronic spontaneous urticaria (CSU). This panel is expected to take place from 10:45 to 11:20 AM ET, providing a platform for InflaRx to demonstrate its pivotal role in developing solutions for these challenging conditions.

Leerink Partners Therapeutics Forum

Another significant event on InflaRx’s calendar is the Leerink Partners Therapeutics Forum, which focuses on inflammation and metabolism. This event is set for July 8th and 9th. In addition to networking with other industry leaders, the company will participate in individual meetings with investors on July 8th. Both events are created to foster deep discussions and engagement with potential stakeholders, allowing InflaRx to present its cutting-edge product pipeline.

About InflaRx N.V.

InflaRx N.V. is at the forefront of biopharmaceutical innovation with a focus on anti-inflammatory therapies. Utilizing its proprietary technologies, the company is dedicated to developing targeted treatments that address the complement activation factor C5a and its receptor, C5aR. This area of research is crucial, as C5a is recognized as a significant factor in the progression of various inflammatory diseases.

The company’s flagship product, vilobelimab, stands out as a first-in-class, intravenously administered monoclonal antibody. This innovative treatment selectively binds to the free C5a protein and has shown promising disease-modifying capabilities along with a favorable safety profile in numerous clinical trials. Furthermore, InflaRx is advancing its small molecule treatment, INF904, which offers a novel oral administration option for patients.

Founded in 2007, InflaRx N.V. maintains offices in both Germany and the United States, solidifying its international presence and dedication to enhancing patient health worldwide. For those eager to learn more about InflaRx and its initiatives, more information is available through their official resources.

Contact Information

InflaRx N.V.
Jan Medina, CFA
Vice President, Head of Investor Relations
Email: IR@inflarx.de

MC Services AG
Katja Arnold, Laurie Doyle, Dr. Regina Lutz
Email: inflarx@mc-services.eu
Europe: +49 89-210 2280
U.S.: +1-339-832-0752

Frequently Asked Questions

What is InflaRx N.V. known for?

InflaRx N.V. specializes in developing innovative anti-inflammatory therapies targeting the complement system.

When will InflaRx present at the investor conferences?

InflaRx will present on June 4th at the Jefferies Global Healthcare Conference and participate in various meetings.

What is vilobelimab?

Vilobelimab is InflaRx's lead product candidate, an intravenous monoclonal antibody targeting free C5a to treat inflammatory diseases.

Where are InflaRx’s offices located?

InflaRx has offices in Jena and Munich, Germany, and Ann Arbor, Michigan, USA.

How can I get in touch with InflaRx?

Interested parties can contact InflaRx through their investor relations email or the provided contact details for further inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 249

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 150

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 114

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 9

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 244

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 168

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 74

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 159

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 74

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 222

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading

Top 5 Most Recently Viewed Articles

Transformative Innovations in AI-Driven Data Center Patenting

Updated Category News Views 238

Insights from the Latest PatentVest Pulse Report In an era where digital advancements are at an all-time high, PatentVest has unveiled their latest findings in the PatentVest Pulse Report. This enlightening report delves into the transformative trends emerging in the AI data center patent landscape. With growing demands for efficient data handling and innovative...

Continue Reading
TransUnion's Q4 Earnings Beat Expectations; Analysts React

Updated Category News Views 232

TransUnion's Impressive Fourth Quarter Earnings TransUnion reported upbeat earnings for the fourth quarter, showcasing a strong performance that caught the attention of market analysts. The company announced earnings of $1.07 per share, surpassing the analyst consensus estimate of $1.02. In addition, quarterly sales rose to $1.171 billion, exceeding expectations of $1.134...

Continue Reading
Tencent Music Entertainment Group Announces Q3 2025 Results Update

Updated Category News Views 333

Tencent Music Entertainment Group to Report Financial Results Tencent Music Entertainment Group (NYSE: TME), a prominent name in the realm of online music and audio entertainment, has made a significant announcement regarding its upcoming financial results. The company is gearing up to reveal its unaudited financial performance for the third quarter of 2025, a vital time...

Continue Reading
AiDash's New Leadership Team Drives Growth and Innovation

Updated Category News Views 132

AiDash's New Leadership Team Drives Growth and Innovation AiDash, an enterprise SaaS company focused on making critical infrastructure industries climate adaptive and resilient, has recently taken significant steps to expand its leadership team. This move comes at a vital time as the company continues to scale its operations, aiming to meet the rising demand for...

Continue Reading
Daily Market Insights: Trading Strategies for Major Stocks

Updated Category News Views 391

Daily Market Trading Strategies for Success Good morning, traders! Today, we’re diving into insights on crucial stocks such as SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA. Our goal is to discuss effective strategies and essential price levels to help you navigate the market with confidence. Market Analysis: Key Price Levels to Watch Using our exclusive formula at...

Continue Reading